US 11814625
Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease
granted A61KA61K47/549A61K47/6911
Quick answer
US patent 11814625 (Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease) held by Carleton University expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Carleton University
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/549, A61K47/6911, A61K9/0085, A61K9/127